The mean of analysts' price targets for Globus Medical (GMED) points to a 25% upside in the stock. W

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globu

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

American Capital Management Inc. acquired a new stake in shares of Globus Medical, Inc. (NYSE: GMED)

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, today announced the

AUDUBON, Pa., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculo

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

PEG-driven GARP picks EnerSys, Globus Medical, DoubleVerify and Match Group pair discounted valuatio

Globus Medical is rated a buy, targeting a 17.5% return over four quarters with a constant 10.56x EV

Globus Medical (GMED) is well positioned to outperform the market, as it exhibits above-average grow

Globus Medical (GMED) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism

Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED)

Globus Medical NYSE: GMED reported second-quarter 2026 revenue of $789.6 million, up 6% from a year

Globus Medical raises 2026 EPS guidance after Q2 margin gains and spine growth while holding sales g

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lo

While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business pe

Globus Medical, Inc. (GMED) Q2 2026 Earnings Call Transcript

Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.70-$4.80 to $4.95-$5.05 vs $4.74 a

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.34 per share which beat the analyst con

AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculo

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Amundi raised its position in Globus Medical, Inc. (NYSE: GMED) by 12.2% during the first quarter, a

Globus Medical and Resmed enter the earnings season with growth drivers intact despite tariff, infla

Get a deeper insight into the potential performance of Globus Medical (GMED) for the quarter ended J

Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lo

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and lower

BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announce

Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price

Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end

Top Wall Street analysts changed their outlook on top names. See all rating changes on our analyst r

Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Overweight and

Cramer says Rocket Companies is a "play" on the idea that new Fed Chair Kevin Warsh will cut

RBC Capital analyst Shagun Singh maintains Globus Medical (NYSE:GMED) with a Outperform and raise

Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and lo

Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price

Globus Medical (NYSE:GMED) raises FY2026 Adj EPS guidance from $4.40-$4.50 to $4.70-$4.80 vs $4.47 a

Globus Medical (NYSE:GMED) reported quarterly earnings of $1.12 per share which beat the analyst con

Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and raises

Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises th

Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and raises the price

Needham analyst David Saxon upgrades Globus Medical (NYSE:GMED) from Hold to Buy and announces $1

Canaccord Genuity analyst Caitlin Cronin maintains Globus Medical (NYSE:GMED) with a Buy and rais

Piper Sandler analyst Matt O'Brien reiterates Globus Medical (NYSE:GMED) with a Overweight an

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced prel

Canaccord Genuity analyst Caitlin Cronin maintains Globus Medical (NYSE:GMED) with a Buy and rais